Loading data
DRTSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 32.07 m USD | 27.02 m USD | 26.42 m USD | 20.89 m USD | 11.45 m USD |
| Operating profit | -42.29 m USD | -36.04 m USD | -35.68 m USD | -32.14 m USD | -13.79 m USD |
| Profit before tax | -42.51 m USD | -31.74 m USD | -29.14 m USD | -33.74 m USD | -27.26 m USD |
| Income tax expense | 121 k USD | 6 k USD | 16 k USD | 20 k USD | 7 k USD |
| Net income (reported basis) | -42.63 m USD | -31.75 m USD | -29.16 m USD | -33.76 m USD | -27.27 m USD |
| Basic earnings per share | -0.53 USD/share | -0.45 USD/share | -0.42 USD/share | -0.53 USD/share | -0.67 USD/share |
| Diluted earnings per share | -0.53 USD/share | -0.45 USD/share | -0.42 USD/share | -0.53 USD/share | -0.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.